Correlation Between Apogee Therapeutics, and 02378MAA9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and 02378MAA9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and 02378MAA9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and AAL 35 15 FEB 32, you can compare the effects of market volatilities on Apogee Therapeutics, and 02378MAA9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of 02378MAA9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and 02378MAA9.

Diversification Opportunities for Apogee Therapeutics, and 02378MAA9

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Apogee and 02378MAA9 is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and AAL 35 15 FEB 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AAL 35 15 and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with 02378MAA9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AAL 35 15 has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and 02378MAA9 go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and 02378MAA9

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 0.42 times more return on investment than 02378MAA9. However, Apogee Therapeutics, Common is 2.41 times less risky than 02378MAA9. It trades about -0.25 of its potential returns per unit of risk. AAL 35 15 FEB 32 is currently generating about -0.41 per unit of risk. If you would invest  5,630  in Apogee Therapeutics, Common on September 4, 2024 and sell it today you would lose (1,016) from holding Apogee Therapeutics, Common or give up 18.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy23.81%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  AAL 35 15 FEB 32

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
AAL 35 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AAL 35 15 FEB 32 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for AAL 35 15 FEB 32 investors.

Apogee Therapeutics, and 02378MAA9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and 02378MAA9

The main advantage of trading using opposite Apogee Therapeutics, and 02378MAA9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, 02378MAA9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 02378MAA9 will offset losses from the drop in 02378MAA9's long position.
The idea behind Apogee Therapeutics, Common and AAL 35 15 FEB 32 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device